Process development of inhalation powders containing simvastatin loaded liposomes using spray drying technology

References

• who.int [Internet]. Cancer. 2022 [cited 2022 Sep 21]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer.
   Google Scholar
• Lemjabbar-Alaoui H, Hassan OU, Yang Y-W, et al. Lung cancer: biology and treatment options. Biochim Biophys Acta. 2015;1856(2):189–210. doi: 10.1016/j.bbcan.2015.08.002.
   PubMed Web of Science ®Google Scholar
• Elkrief A, Joubert P, Florescu M, et al. Therapeutic landscape of metastatic non-small-cell lung cancer in Canada in 2020. Curr Oncol. 2020;27(1):52–60. doi: 10.3747/co.27.5953.
   PubMed Web of Science ®Google Scholar
• Ahmadi M, Amiri S, Pecic S, et al. Pleiotropic effects of statins: a focus on cancer. Biochim Biophys Acta Mol Basis Dis. 2020;1866(12):165968. doi: 10.1016/j.bbadis.2020.165968.
   PubMed Web of Science ®Google Scholar
• Licarete E, Sesarman A, Banciu M. Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems. J Microencapsul. 2015;32(7):619–631. doi: 10.3109/02652048.2015.1073383.
   PubMed Web of Science ®Google Scholar
• Bedi O, Dhawan V, Sharma PL, et al. Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(7):695–712. doi: 10.1007/s00210-016-1252-4.
   PubMed Web of Science ®Google Scholar
• Mohammadkhani N, Gharbi S, Rajani HF, et al. Statins: complex outcomes but increasingly helpful treatment options for patients. Eur J Pharmacol. 2019;863(July):172704. doi: 10.1016/j.ejphar.2019.172704.
   PubMedGoogle Scholar
• Xu L, Dong X-W, Shen L-L, et al. Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma. Int Immunopharmacol. 2012;12(4):556–564. doi: 10.1016/j.intimp.2012.01.012.
   PubMed Web of Science ®Google Scholar
• Barbalata C-I, Porfire AS, Casian T, et al. The use of the QbD approach to optimize the Co-loading of simvastatin and doxorubicin in liposomes for a synergistic anticancer effect. Pharmaceuticals. 2022;15(10):1211. doi: 10.3390/ph15101211.
   Web of Science ®Google Scholar
• Wang F, Liu W, Ning J, et al. Simvastatin suppresses proliferation and migration in non-small cell lung cancer via pyroptosis. Int J Biol Sci. 2018;14(4):406–417. doi: 10.7150/ijbs.23542.
   PubMed Web of Science ®Google Scholar
• Search of: simvastatin | lung disease – list results – ClinicalTrials.gov.; 2022 [cited 2022 Sep 27]. Available from: https://clinicaltrials.gov/ct2/results?cond=lung+disease&term=simvastatin&cntry=&state=&city=&dist=.
   Google Scholar
• Search of: statins | Lung diseases – list results – ClinicalTrials.gov.; 2022 [cited 2022 Sep 28]. Available from: https://clinicaltrials.gov/ct2/results?cond=Lung+Diseases&term=statins&cntry=&state=&city=&dist=.
   Google Scholar
• Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol. 2005;19(1):117–125. doi: 10.1111/j.1472-8206.2004.00299.x.
   PubMed Web of Science ®Google Scholar
• Andrade F, Rafael D, Videira M, et al. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Adv Drug Deliv Rev. 2013;65(13–14):1816–1827. doi: 10.1016/j.addr.2013.07.020.
   PubMed Web of Science ®Google Scholar
• Abdelaziz HM, Gaber M, Abd-Elwakil MM, et al. Inhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregates. J Control Release. 2018;269(October 2017):374–392. doi: 10.1016/j.jconrel.2017.11.036.
   PubMedGoogle Scholar
• Mehta PP, Ghoshal D, Pawar AP, et al. Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance. J Drug Delivery Sci Technol. 2020;56(December 2019):101509. doi: 10.1016/j.jddst.2020.101509.
   Google Scholar
• Chou AJ, Gupta R, Bell MD, et al. Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung. Pediatr Blood Cancer. 2013;60(4):580–586. doi: 10.1002/pbc.24438.
   PubMed Web of Science ®Google Scholar
• Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm. 2010;392(1–2):1–19. doi: 10.1016/j.ijpharm.2010.03.017.
   PubMed Web of Science ®Google Scholar
• Griffith DE, Eagle G, Thomson R, et al. ʻAmikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT) a prospective, open-label, randomized studyʼ. Am J Respir Crit Care Med. 2018;198(12):1559–1569. doi: 10.1164/rccm.201807-1318OC.
   PubMed Web of Science ®Google Scholar
• Yu JY, Chuesiang P, Shin GH, et al. Post-processing techniques for the improvement of liposome stability. Pharmaceutics. 2021;13(7):1023. doi: 10.3390/pharmaceutics13071023.
   PubMed Web of Science ®Google Scholar
• Porfire A, Tomuta I, Muntean D, et al. Optimizing long-circulating liposomes for delivery of simvastatin to C26 Colon carcinoma cells. J Liposome Res. 2015;25(4):261–269. doi: 10.3109/08982104.2014.987787.
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia. Supplement 11.2. Preparations for inhalation: Aerodynamic assessment of fine particles (reference 01/2008:20918).
   Google Scholar
• Ambrus R, Benke E, Farkas Á, et al. Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties. Eur J Pharm Sci. 2018;123:20–27. doi: 10.1016/j.ejps.2018.07.030.
   PubMed Web of Science ®Google Scholar
• Koblinger L, Hofmann W. Monte Carlo modeling of aerosol deposition in human lungs. Part I: simulation of particle transport in a stochastic lung structure. J Aerosol Sci. 1990;21(5):661–674. doi: 10.1016/0021-8502(90)90121-D.
   Web of Science ®Google Scholar
• Rudokas M, Najlah M, Alhnan MA, et al. Liposome delivery systems for inhalation: a critical review highlighting formulation issues and anticancer applications. Med Princ Pract. 2016;25(Suppl 2):60–72. doi: 10.1159/000445116.
   PubMed Web of Science ®Google Scholar
• Yu Z, Liu X, Chen H, et al. Naringenin-Loaded dipalmitoylphosphatidylcholine phytosome dry powders for inhaled treatment of acute lung injury. J Aerosol Med Pulm Drug Deliv. 2020;33(4):194–204. doi: 10.1089/jamp.2019.1569.
   PubMed Web of Science ®Google Scholar
• Chono S, Fukuchi R, Seki T, et al. Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery. J Control Release. 2009;137(2):104–109. doi: 10.1016/j.jconrel.2009.03.019.
   PubMed Web of Science ®Google Scholar
• Abdulbaqi IM, Assi RA, Yaghmur A, et al. Pulmonary delivery of anticancer drugs via lipid-based nanocarriers for the treatment of lung cancer: an update. Pharmaceuticals. 2021;14(8):725. doi: 10.3390/ph14080725.
   Web of Science ®Google Scholar
• Vicente J, Pinto J, Menezes J, et al. Fundamental analysis of particle formation in spray drying. Powder Technol. 2013;247:1–7. doi: 10.1016/j.powtec.2013.06.038.
   Web of Science ®Google Scholar
• Corzo C, Fuchsbichler A, Savencu I, et al. Lipid-microparticles for pulmonary delivery of active pharmaceutical ingredients: Impact of lipid crystallization on spray-drying processability. Int J Pharm. 2021;610(July):121259. doi: 10.1016/j.ijpharm.2021.121259.
   PubMedGoogle Scholar
• van den Hoven JM, Metselaar JM, Storm G, et al. Cyclodextrin as membrane protectant in spray-drying and freeze-drying of PEGylated liposomes. Int J Pharm. 2012;438(1–2):209–216. doi: 10.1016/j.ijpharm.2012.08.046.
   PubMed Web of Science ®Google Scholar
• Khatib I, Chow MYT, Ruan J, et al. Modeling of a spray drying method to produce ciprofloxacin nanocrystals inside the liposomes utilizing a response surface methodology: Box-Behnken experimental design. Int J Pharm. 2021;597(February):120277. doi: 10.1016/j.ijpharm.2021.120277.
   PubMedGoogle Scholar
• Salade L, Wauthoz N, Vermeersch M, et al. Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery. Eur J Pharm Biopharm. 2018;129(June):257–266. doi: 10.1016/j.ejpb.2018.06.011.
   PubMedGoogle Scholar
• Yue-Xing C, Fei-Fei Y, Han W, et al. The effect of L-leucine on the stabilization and inhalability of spray-dried solid lipid nanoparticles for pulmonary drug delivery. J Drug Delivery Sci Technol. 2018;46(151):474–481. doi: 10.1016/j.jddst.2018.06.011.
   Google Scholar
• Chvatal A, Farkas Á, Balásházy I, et al. Aerodynamic properties and in silico deposition of meloxicam potassium incorporated in a carrier-free DPI pulmonary system. Int J Pharm. 2017;520(1–2):70–78. doi: 10.1016/j.ijpharm.2017.01.070.
   PubMedGoogle Scholar
• Gandhi M, Pandya T, Gandhi R, et al. Inhalable liposomal dry powder of gemcitabine-HCl: formulation, in vitro characterization and in vivo studies. Int J Pharm. 2015;496(2):886–895. doi: 10.1016/j.ijpharm.2015.10.020.
   PubMed Web of Science ®Google Scholar
• Zillen D, Beugeling M, Hinrichs WLJ, et al. Natural and bioinspired excipients for dry powder inhalation formulations. Curr Opin Colloid Interface Sci. 2021;56:101497. doi: 10.1016/j.cocis.2021.101497.
   Web of Science ®Google Scholar
• Chen K-H, Mueannoom W, Gaisford S, et al. Investigation into the effect of varying l -leucine concentration on the product characteristics of spray-dried liposome powders. J Pharm Pharmacol. 2012;64(10):1412–1424. doi: 10.1111/j.2042-7158.2012.01521.x.
   PubMed Web of Science ®Google Scholar
• Maa YF, Costantino HR, Nguyen PA, et al. The effect of operating and formulation variables on the morphology of spray-dried protein particles. Pharm Dev Technol. 1997;2(3):213–223. doi: 10.3109/10837459709031441.
   PubMedGoogle Scholar
• Khatib I, Khanal D, Ruan J, et al. Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation. Int J Pharm. 2019;566(June):641–651. doi: 10.1016/j.ijpharm.2019.05.068.
   PubMedGoogle Scholar
• Khatib I, Tang P, Ruan J, et al. Formation of ciprofloxacin nanocrystals within liposomes by spray drying for controlled release via inhalation. Int J Pharm. 2020;578(January):119045. doi: 10.1016/j.ijpharm.2020.119045.
   PubMedGoogle Scholar
• Briuglia M-L, Rotella C, McFarlane A, et al. Influence of cholesterol on liposome stability and on in vitro drug release. Drug Deliv Transl Res. 2015;5(3):231–242. doi: 10.1007/s13346-015-0220-8.
   PubMed Web of Science ®Google Scholar
• Lu W, Rades T, Rantanen J, et al. Amino acids as stabilizers for spray-dried simvastatin powder for inhalation. Int J Pharm. 2019;572(September):118724. doi: 10.1016/j.ijpharm.2019.118724.
   PubMedGoogle Scholar
• Mukhtar M, Szakonyi Z, Farkas Á, et al. Freeze-dried vs spray-dried nanoplex DPIs based on chitosan and its derivatives conjugated with hyaluronic acid for tuberculosis: in vitro aerodynamic and in silico deposition profiles. Eur Polym J. 2021;160(September):110775. doi: 10.1016/j.eurpolymj.2021.110775.
   Google Scholar
• PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 5997, Cholesterol; [cited 2022 Oct 10]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Cholesterol#section=Chemical-and-Physical-Properties.
   Google Scholar
• FDA. Metered dose inhaler (MDI) and dry powder inhaler (DPI) products – quality considerations. Center for Drug Evaluation and Research (CDER), Silver Spring, (April); 2018. Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070573.pdf?utm_campaign=SBIA%3A Metered Dose Inhaler %28MDI%29 and Dry Powder Inhaler %28DPI%29 Products – Quality Considerations&utm_medium=email&utm_source=Eloqua.
   Google Scholar
• Redondo-Morata L, Lea Sanford R, Andersen OS, et al. Effect of statins on the nanomechanical properties of supported lipid bilayers. Biophys J. 2016;111(2):363–372. doi: 10.1016/j.bpj.2016.06.016.
   PubMed Web of Science ®Google Scholar
• Sariisik E, Koçak M, Kucuk Baloglu F, et al. Interaction of the cholesterol reducing agent simvastatin with zwitterionic DPPC and charged DPPG phospholipid membranes. Biochim Biophys Acta Biomembr. 2019;1861(4):810–818. doi: 10.1016/j.bbamem.2019.01.014.
   PubMed Web of Science ®Google Scholar
• Barbălată CI, Porfire AS, Sesarman A, et al. A screening study for the development of simvastatin-doxorubicin liposomes, a co-formulation with future perspectives in colon cancer therapy. Pharmaceutics. 2021;13(10):1526. doi: 10.3390/pharmaceutics13101526.
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Zhang T, et al. A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci. 2015;10(2):81–98. doi: 10.1016/j.ajps.2014.09.004.
   Web of Science ®Google Scholar
• Bosquillon C, Lombry C, Préat V, et al. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Control Release. 2001;70(3):329–339. doi: 10.1016/s0168-3659(00)00362-x.
   PubMed Web of Science ®Google Scholar
• Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems – a review (part 2). Trop J Pharm Res. 2013;12(2):265–273. doi: 10.4314/tjpr.v12i2.20.
   Google Scholar
• Morini MA, Sierra MB, Pedroni VI, et al. Influence of temperature, anions and size distribution on the zeta potential of DMPC, DPPC and DMPE lipid vesicles. Colloids Surf B Biointerfaces. 2015;131:54–58. doi: 10.1016/j.colsurfb.2015.03.054.
   PubMed Web of Science ®Google Scholar
• Party P, Bartos C, Farkas Á, et al. Formulation and in vitro and in silico characterization of “nano-in-micro” dry powder inhalers containing meloxicam. Pharmaceutics. 2021;13(2):211. doi: 10.3390/pharmaceutics13020211.
   PubMed Web of Science ®Google Scholar
• Qiu F. Practical considerations, accelerated predictive stability (APS): fundamentals and pharmaceutical industry practices. London: Elsevier Inc.; 2018. p. 75–102.
   Google Scholar
• Wang X, Wan W, Lu J, et al. Effects of L-leucine on the properties of spray-dried swellable microparticles with wrinkled surfaces for inhalation therapy of pulmonary fibrosis. Int J Pharm. 2021;610:121223. doi: 10.1016/j.ijpharm.2021.121223.
   PubMedGoogle Scholar
• Wang T, Jiang Y, Chu H, et al. Doxorubicin and lovastatin co-delivery liposomes for synergistic therapy of liver cancer. J Drug Delivery Sci Technol. 2019;52(April):452–459. doi: 10.1016/j.jddst.2019.04.045.
   Google Scholar
• International Council for Harmonisation. ICH harmonised tripartite guideline, pharmaceutical development Q8(R2). ICH Harmon Tripartite Guideline. 2009;8(August):1–28.
   Google Scholar
• Wang L, Hu X, Shen B, et al. Enhanced stability of liposomes against solidification stress during freeze-drying and spray-drying by coating with calcium alginate. J Drug Delivery Sci Technol. 2015;30:163–170. pp: doi: 10.1016/j.jddst.2015.10.012.
   Web of Science ®Google Scholar
• Chaurasiya B, Zhao YY. Dry powder for pulmonary delivery: a comprehensive review. Pharmaceutics. 2020;13(1):31. doi: 10.3390/pharmaceutics13010031.
   PubMed Web of Science ®Google Scholar
• Newman SP, Busse WW. Evolution of dry powder inhaler design, formulation, and performance. Respir Med. 2002;96(5):293–304. doi: 10.1053/rmed.2001.1276.
   PubMed Web of Science ®Google Scholar
• Noriega-Fernandes B, Malmlöf M, Nowenwik M, et al. Dry powder inhaler formulation comparison: study of the role of particle deposition pattern and dissolution. Int J Pharm. 2021;607(May):121025. doi: 10.1016/j.ijpharm.2021.121025.
   PubMedGoogle Scholar
• Dash S, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharmaceutica - Drug Research. 2010;67(3):217–223.
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhu C, Ma Y. Densities and viscosities of erythritol, xylitol, and mannitol in l -ascorbic acid aqueous solutions at T = (293.15 to 323.15) K. J Chem Eng Data. 2013;58(11):2970–2978. doi: 10.1021/je400395u.
   Web of Science ®Google Scholar